Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Current Assets (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Current Assets of $4.62 billion for Q2 2026, up 26.8% from $3.64 billion a year earlier and up 9.5% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Alnylam Pharmaceuticals' Current Assets came in at $4.05 billion, up 22.9% from FY2024.

  • Annual Current Assets has increased for three consecutive years, with a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Current Assets was $3.3 billion in FY2024 (+10.5%), $2.98 billion in FY2023 (+10.8%), $2.69 billion in FY2022 (-4.1%) and $2.81 billion in FY2021 (+7.4%).
  • The Q2 2026 figure stands as the highest quarterly Current Assets in data going back to Q4 2009.
  • On a year-over-year basis, Current Assets has increased in each of the last 13 quarters, with growth averaging 18.0% over the last eight quarters.
  • The strongest year-over-year quarter for Current Assets in the past five years was Q1 2026, with growth of 29.1%; the weakest was Q2 2022, with a decline of 9.3%.
  • According to Business Quant data, Current Assets for the three prior quarters was $4.22 billion (Q1 2026), $4.05 billion (Q4 2025) and $3.95 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 59.77 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 33.67 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 27.97 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 12.54 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 4.62 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.62 Bn
Mar 31, 2026 4.22 Bn
Dec 31, 2025 4.05 Bn
Sep 30, 2025 3.95 Bn
Jun 30, 2025 3.64 Bn
Mar 31, 2025 3.27 Bn
Dec 31, 2024 3.30 Bn
Sep 30, 2024 3.36 Bn
Jun 30, 2024 3.17 Bn
Mar 31, 2024 2.99 Bn
Dec 31, 2023 2.98 Bn
Sep 30, 2023 2.99 Bn
Jun 30, 2023 2.52 Bn
Mar 31, 2023 2.54 Bn
Dec 31, 2022 2.69 Bn
Sep 30, 2022 2.69 Bn
Jun 30, 2022 2.47 Bn
Mar 31, 2022 2.59 Bn
Dec 31, 2021 2.81 Bn
Sep 30, 2021 2.68 Bn
API Access

Alnylam Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ALNY&period=max&api_key=YOUR_API_KEY